Skip to main content
Top
Published in: Inflammation 1/2017

01-02-2017 | ORIGINAL ARTICLE

The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis

Authors: Yingying Cai, Hu Shen, Chaoyan Qin, Jinfeng Zhou, Weiming Lai, Juping Pan, Changsheng Du

Published in: Inflammation | Issue 1/2017

Login to get access

Abstract

Multiple sclerosis is a CD4+ T cell-mediated autoimmune disease of the central nervous system. The unbalance of the cytokines and transcription factors critical for CD4+ T cell differentiation and function is probably the main reason that causes MS. We detected the mRNA expression changes of key cytokines and transcription factors which are critical for Th1, Th2, Th17, and Treg cell differentiation and function in different tissues during EAE pathogenesis. We fund that each gene not only has its own featured expression changes, but also has interaction with one another, which composes a network of immunity. Understanding the roles of key cytokines and transcription factors in these processes will help to understand disease pathogenesis and supply indications for disease therapy.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lovett-Racke, A.E., Y. Yang, and M.K. Racke. 2011. Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis? Biochimica et Biophysica Acta 1812: 246–251.CrossRefPubMed Lovett-Racke, A.E., Y. Yang, and M.K. Racke. 2011. Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis? Biochimica et Biophysica Acta 1812: 246–251.CrossRefPubMed
3.
go back to reference Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248.CrossRefPubMed Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248.CrossRefPubMed
4.
go back to reference Kurata, H., H.J. Lee, A. O’Garra, and N. Arai. 1999. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677–688.CrossRefPubMed Kurata, H., H.J. Lee, A. O’Garra, and N. Arai. 1999. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677–688.CrossRefPubMed
5.
go back to reference Gorelik, L., S. Constant, and R.A. Flavell. 2002. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. Journal of Experimental Medicine 195: 1499–1505.CrossRefPubMedPubMedCentral Gorelik, L., S. Constant, and R.A. Flavell. 2002. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. Journal of Experimental Medicine 195: 1499–1505.CrossRefPubMedPubMedCentral
6.
go back to reference Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179–189.CrossRefPubMed Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179–189.CrossRefPubMed
7.
go back to reference Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of TH17 cells. Seminars in Immunology 19: 383–393.CrossRefPubMed Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of TH17 cells. Seminars in Immunology 19: 383–393.CrossRefPubMed
8.
go back to reference Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R.A. Sobel, K.W. Wucherpfennig, and V.K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 101: 15434–15439.CrossRefPubMedPubMedCentral Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R.A. Sobel, K.W. Wucherpfennig, and V.K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 101: 15434–15439.CrossRefPubMedPubMedCentral
9.
go back to reference Horwitz, D.A., S.G. Zheng, and J.D. Gray. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends in Immunology 29: 429–435.CrossRefPubMed Horwitz, D.A., S.G. Zheng, and J.D. Gray. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends in Immunology 29: 429–435.CrossRefPubMed
10.
go back to reference Yao, Y., W. Li, M.H. Kaplan, and C.H. Chang. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. Journal of Experimental Medicine 201: 1899–1903.CrossRefPubMedPubMedCentral Yao, Y., W. Li, M.H. Kaplan, and C.H. Chang. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. Journal of Experimental Medicine 201: 1899–1903.CrossRefPubMedPubMedCentral
11.
go back to reference Qian, X., L. Gu, H. Ning, Y. Zhang, E.C. Hsueh, M. Fu, X. Hu, L. Wei, D.F. Hoft, and J. Liu. 2013. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Journal of Immunology 190: 5894–5902.CrossRef Qian, X., L. Gu, H. Ning, Y. Zhang, E.C. Hsueh, M. Fu, X. Hu, L. Wei, D.F. Hoft, and J. Liu. 2013. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Journal of Immunology 190: 5894–5902.CrossRef
12.
go back to reference Wang, L., C. Du, J. Lv, W. Wei, Y. Cui, and X. Xie. 2011. Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. Journal of Immunology 187: 2336–2345.CrossRef Wang, L., C. Du, J. Lv, W. Wei, Y. Cui, and X. Xie. 2011. Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. Journal of Immunology 187: 2336–2345.CrossRef
13.
go back to reference Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. European Journal of Immunology 26: 1641–1646.CrossRefPubMed Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. European Journal of Immunology 26: 1641–1646.CrossRefPubMed
14.
go back to reference Smits, H.H., J.G. van Rietschoten, C.M. Hilkens, R. Sayilir, F. Stiekema, M.L. Kapsenberg, and E.A. Wierenga. 2001. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. European Journal of Immunology 31: 1055–1065.CrossRefPubMed Smits, H.H., J.G. van Rietschoten, C.M. Hilkens, R. Sayilir, F. Stiekema, M.L. Kapsenberg, and E.A. Wierenga. 2001. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. European Journal of Immunology 31: 1055–1065.CrossRefPubMed
15.
go back to reference Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Journal of Experimental Medicine 181: 381–386.CrossRefPubMed Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Journal of Experimental Medicine 181: 381–386.CrossRefPubMed
16.
go back to reference Schiering, C., T. Krausgruber, A. Chomka, A. Frohlich, K. Adelmann, E.A. Wohlfert, J. Pott, T. Griseri, J. Bollrath, A.N. Hegazy, O.J. Harrison, B.M. Owens, M. Lohning, Y. Belkaid, P.G. Fallon, and F. Powrie. 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513: 564–568.CrossRefPubMedPubMedCentral Schiering, C., T. Krausgruber, A. Chomka, A. Frohlich, K. Adelmann, E.A. Wohlfert, J. Pott, T. Griseri, J. Bollrath, A.N. Hegazy, O.J. Harrison, B.M. Owens, M. Lohning, Y. Belkaid, P.G. Fallon, and F. Powrie. 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513: 564–568.CrossRefPubMedPubMedCentral
17.
go back to reference Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. Journal of Experimental Medicine 193: 427–434.CrossRefPubMedPubMedCentral Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. Journal of Experimental Medicine 193: 427–434.CrossRefPubMedPubMedCentral
18.
go back to reference Wohlfert, E.A., J.R. Grainger, N. Bouladoux, J.E. Konkel, G. Oldenhove, C.H. Ribeiro, J.A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, W.E. Paul, R. Bosselut, G. Wei, K. Zhao, M. Oukka, J. Zhu, and Y. Belkaid. 2011. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. Journal of Clinical Investigation 121: 4503–4515.CrossRefPubMedPubMedCentral Wohlfert, E.A., J.R. Grainger, N. Bouladoux, J.E. Konkel, G. Oldenhove, C.H. Ribeiro, J.A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, W.E. Paul, R. Bosselut, G. Wei, K. Zhao, M. Oukka, J. Zhu, and Y. Belkaid. 2011. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. Journal of Clinical Investigation 121: 4503–4515.CrossRefPubMedPubMedCentral
19.
go back to reference Ponomarev, E.D., K. Maresz, Y. Tan, and B.N. Dittel. 2007. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. Journal of Neuroscience 27: 10714–10721.CrossRefPubMed Ponomarev, E.D., K. Maresz, Y. Tan, and B.N. Dittel. 2007. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. Journal of Neuroscience 27: 10714–10721.CrossRefPubMed
20.
go back to reference Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236–240.CrossRefPubMedPubMedCentral Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236–240.CrossRefPubMedPubMedCentral
21.
go back to reference Dhib-Jalbut, S., H. Jiang, and G.J. Williams. 1996. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. Journal of Neuroimmunology 71: 215–222.CrossRefPubMed Dhib-Jalbut, S., H. Jiang, and G.J. Williams. 1996. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. Journal of Neuroimmunology 71: 215–222.CrossRefPubMed
22.
go back to reference Maimone, D., G.C. Guazzi, and P. Annunziata. 1997. IL-6 detection in multiple sclerosis brain. Journal of Neurological Sciences 146: 59–65.CrossRef Maimone, D., G.C. Guazzi, and P. Annunziata. 1997. IL-6 detection in multiple sclerosis brain. Journal of Neurological Sciences 146: 59–65.CrossRef
23.
go back to reference McGeachy, M.J., K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, T. McClanahan, and D.J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature Immunology 8: 1390–1397.CrossRefPubMed McGeachy, M.J., K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, T. McClanahan, and D.J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature Immunology 8: 1390–1397.CrossRefPubMed
24.
go back to reference Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 8: 967–974.CrossRefPubMed Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 8: 967–974.CrossRefPubMed
25.
go back to reference Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nature Medicine 13: 1173–1175.CrossRefPubMedPubMedCentral Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nature Medicine 13: 1173–1175.CrossRefPubMedPubMedCentral
26.
go back to reference Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744–748.CrossRefPubMed Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744–748.CrossRefPubMed
27.
go back to reference McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. Blumenschein, T.K. McClanahan, J.J. O’Shea, and D.J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nature Immunology 10: 314–324.CrossRefPubMedPubMedCentral McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. Blumenschein, T.K. McClanahan, J.J. O’Shea, and D.J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nature Immunology 10: 314–324.CrossRefPubMedPubMedCentral
28.
go back to reference Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 4: 330–336.CrossRefPubMed Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 4: 330–336.CrossRefPubMed
29.
go back to reference Marie, J.C., J.J. Letterio, M. Gavin, and A.Y. Rudensky. 2005. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. Journal of Experimental Medicine 201: 1061–1067.CrossRefPubMedPubMedCentral Marie, J.C., J.J. Letterio, M. Gavin, and A.Y. Rudensky. 2005. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. Journal of Experimental Medicine 201: 1061–1067.CrossRefPubMedPubMedCentral
30.
go back to reference Rollnik, J.D., E. Sindern, C. Schweppe, and J.P. Malin. 1997. Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurologica Scandinavica 96: 101–105.CrossRefPubMed Rollnik, J.D., E. Sindern, C. Schweppe, and J.P. Malin. 1997. Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurologica Scandinavica 96: 101–105.CrossRefPubMed
31.
go back to reference Lalive, P.H., R. Paglinawan, G. Biollaz, E.A. Kappos, D.P. Leone, U. Malipiero, J.B. Relvas, M. Moransard, T. Suter, and A. Fontana. 2005. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European Journal of Immunology 35: 727–737.CrossRefPubMed Lalive, P.H., R. Paglinawan, G. Biollaz, E.A. Kappos, D.P. Leone, U. Malipiero, J.B. Relvas, M. Moransard, T. Suter, and A. Fontana. 2005. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European Journal of Immunology 35: 727–737.CrossRefPubMed
32.
go back to reference Chaudhry, A., R.M. Samstein, P. Treuting, Y. Liang, M.C. Pils, J.M. Heinrich, R.S. Jack, F.T. Wunderlich, J.C. Bruning, W. Muller, and A.Y. Rudensky. 2011. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566–578.CrossRefPubMedPubMedCentral Chaudhry, A., R.M. Samstein, P. Treuting, Y. Liang, M.C. Pils, J.M. Heinrich, R.S. Jack, F.T. Wunderlich, J.C. Bruning, W. Muller, and A.Y. Rudensky. 2011. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566–578.CrossRefPubMedPubMedCentral
33.
go back to reference Bettelli, E., M.P. Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. Journal of Immunology 161: 3299–3306. Bettelli, E., M.P. Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. Journal of Immunology 161: 3299–3306.
Metadata
Title
The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis
Authors
Yingying Cai
Hu Shen
Chaoyan Qin
Jinfeng Zhou
Weiming Lai
Juping Pan
Changsheng Du
Publication date
01-02-2017
Publisher
Springer US
Published in
Inflammation / Issue 1/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0469-1

Other articles of this Issue 1/2017

Inflammation 1/2017 Go to the issue